Exenatide
Glucagon-Like Peptide-1 (Glp-1) Analogues
Sold as Byetta · Bydureon
- Drug class
- Glucagon-Like Peptide-1 (Glp-1) Analogues
- Availability
- See label
- Markets covered
- 2
- Products on record
- 25
Overview
Exenatide is an active pharmaceutical ingredient in the Glucagon-Like Peptide-1 (Glp-1) Analogues group (A10BJ). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 23 | May 1, 2026 |
| EU European Union | EMA | 2 | November 21, 2024 |
GBUnited Kingdom· MHRA
23 products
Uses
Bydureon is indicated in adults, adolescents and children aged 10 years and above with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose-lowering medicinal products including basal insulin, when the therapy in use, together with diet and exercise, does not provide adequate glycaemic control.
1.
How to take
EUEuropean Union· EMA
2 products
Uses
Bydureon is indicated in adults, adolescents and children aged 10 years and above with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose-lowering medicinal products including basal insulin, when the therapy in use, together with diet and exercise, does not provide adequate glycaemic control.
1.
How to take
Drug interactions
Known interactions involving Exenatide. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 277. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PLGB179010315 · revised May 1, 2026
- [2]European Medicines Agency · EMEA/H/C/002020 · revised November 21, 2024
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.